Methods for the treatment of vascular disorders
US6472401B2 · kind B2 · utility
2Cited by
4References
15Claims
0Family size
Assignee
Inventor
Key dates
| Filing date | Feb 12, 2001 |
| Grant date | Oct 29, 2002 |
| Priority date | — |
| Expiry date | Feb 12, 2021 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61P25/32
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The present invention provides methods of treatment of mental and vascular disorders. In one embodiment, the present invention contemplates the administration of an anti-allergic medication to reduce a patient's symptoms of mental or vascular disorder. The patient may or may not suffer from allergic responses. Likewise, the methods of the present invention may be used to reduce or prevent the symptoms of a mental or vascular disorder. In a preferred embodiment, the anti-allergic medication is a non-sedating or low-sedating antihistamine such as loratadine or desloratadine.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.